S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
Own Dollar General? Hurry and take this advice before earnings
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Stock market today: Global shares trade mostly lower ahead of updates on jobs, inflation
All the trading advice you’ve ever received boils down to this (Ad)
AppLovin (APP): losing its shareholders lovin'?
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
Own Dollar General? Hurry and take this advice before earnings
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Stock market today: Global shares trade mostly lower ahead of updates on jobs, inflation
All the trading advice you’ve ever received boils down to this (Ad)
AppLovin (APP): losing its shareholders lovin'?
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
Own Dollar General? Hurry and take this advice before earnings
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Stock market today: Global shares trade mostly lower ahead of updates on jobs, inflation
All the trading advice you’ve ever received boils down to this (Ad)
AppLovin (APP): losing its shareholders lovin'?
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
Own Dollar General? Hurry and take this advice before earnings
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Stock market today: Global shares trade mostly lower ahead of updates on jobs, inflation
All the trading advice you’ve ever received boils down to this (Ad)
AppLovin (APP): losing its shareholders lovin'?
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny

Cresco Labs Stock Price, News & Analysis (OTCMKTS:CRLBF)

$1.79
+0.09 (+5.45%)
(As of 12/1/2023 08:55 PM ET)
Compare
Today's Range
$1.62
$1.82
50-Day Range
$1.11
$2.13
52-Week Range
$1.00
$4.20
Volume
581,400 shs
Average Volume
685,395 shs
Market Capitalization
$620.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.94

Cresco Labs MarketRank™ Stock Analysis

Analyst Rating
Hold
2.29 Rating Score
Upside/​Downside
955.4% Upside
$18.94 Price Target
Short Interest
Healthy
0.48% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.41) to ($0.07) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.69 out of 5 stars


CRLBF stock logo

About Cresco Labs Stock (OTCMKTS:CRLBF)

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. Cresco Labs Inc. was incorporated in 1990 and is headquartered in Chicago, Illinois.

CRLBF Stock Price History

CRLBF Stock News Headlines

Is This The Most Overlooked Gold Investment Strategy of 2024?
There is little debate on the potential of gold in the next year and decade. The real issue becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks.
Cresco Labs Shares Unwind Yesterday's Gains
Is This The Most Overlooked Gold Investment Strategy of 2024?
There is little debate on the potential of gold in the next year and decade. The real issue becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks.
Cresco Labs Reports Third Quarter 2023 Financial Results
Cresco Labs Unlocks $32 Million in Non-Dilutive Capital
Where Will Cresco Labs Be in 3 Years?
See More Headlines
Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2023
Today
12/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CRLBF
Fax
N/A
Employees
3,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$18.94
High Stock Price Target
$34.00
Low Stock Price Target
$2.50
Potential Upside/Downside
+955.4%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
7 Analysts

Profitability

Net Income
$-212,050,000.00
Pretax Margin
-40.47%

Debt

Sales & Book Value

Annual Sales
$842.68 million
Book Value
$1.23 per share

Miscellaneous

Free Float
N/A
Market Cap
$620.15 million
Optionable
Not Optionable
Beta
2.46
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Thomas J. Manning (Age 67)
    Executive Chairman of the Board
    Comp: $800.05k
  • Mr. Charles Bachtell (Age 44)
    Co-Founder, CEO & Director
    Comp: $999.85k
  • Mr. Robert M. Sampson (Age 48)
    Co-Founder & Independent Director
  • Mr. Dennis M. Olis (Age 60)
    Chief Financial Officer
    Comp: $622.85k
  • Mr. Ty Gent (Age 64)
    Chief Operating Officer
  • Ms. Brenna Albert CPA
    Senior VP and Controller of Accounting, Treasury & Tax
  • Mr. Zach Marburger (Age 38)
    Chief Information Officer
  • Jake Graves
    Manager of Investor Relations
  • Mr. John Schetz (Age 45)
    General Counsel
  • Mr. Jason Erkes (Age 52)
    Chief Communications Officer














CRLBF Stock Analysis - Frequently Asked Questions

Should I buy or sell Cresco Labs stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRLBF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRLBF, but not buy additional shares or sell existing shares.
View CRLBF analyst ratings
or view top-rated stocks.

What is Cresco Labs' stock price target for 2024?

7 Wall Street research analysts have issued 1 year target prices for Cresco Labs' stock. Their CRLBF share price targets range from $2.50 to $34.00. On average, they expect the company's stock price to reach $18.94 in the next twelve months. This suggests a possible upside of 955.4% from the stock's current price.
View analysts price targets for CRLBF
or view top-rated stocks among Wall Street analysts.

How have CRLBF shares performed in 2023?

Cresco Labs' stock was trading at $1.80 at the beginning of the year. Since then, CRLBF stock has decreased by 0.3% and is now trading at $1.7943.
View the best growth stocks for 2023 here
.

How were Cresco Labs' earnings last quarter?

Cresco Labs Inc. (OTCMKTS:CRLBF) posted its quarterly earnings data on Wednesday, November, 15th. The company reported ($0.04) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.04). The firm earned $190.56 million during the quarter, compared to the consensus estimate of $184.75 million. Cresco Labs had a negative net margin of 43.40% and a negative trailing twelve-month return on equity of 11.72%.

How do I buy shares of Cresco Labs?

Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:CRLBF) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -